[The efficiency of mammographic mass screening (author's transl)].
After commenting the assessment of the benefits of medical measures some remarks are made concerning the risk of mammography which has been discussed in detail else where. The benefit of mammography for screening asymptomatic women is estimated on the basis of figures from the literature applying four criteria; 1. Results of the HIP-study, 2. clinically occult breast cancers, 3. clinically occult cancers without axillary nodal involvement, 4. clinically occult "minimal" cancers. On the basis of 10 years-survival it follows that 7% of all breast cancers will be additionally "curable" through screening by mammography. This age-independent value has to be considered apart from risk of radiation induced cancer and benefit/risk-ratios, which are strongly agedependent. Costs of mammography and the screening of high-risk groups are briefly considered.
D000328:Adult; D005260:Female; D005860:Germany, West; D006801:Humans; D008327:Mammography / Q000009:adverse effects / Q000191:economics / Q000592:standards*; D008403:Mass Screening; D008875:Middle Aged; D012306:Risk
Zur Effizienz mammographischer Reihenuntersuchungen.